Garland Marshall, PhD, professor of biochemistry and molecular biophysics, in Washington University School of Medicine in St. Louis and of biomedical engineering, in the univeristy’s School of Engineering & Applied Science, has received a $50,000 grant from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) for research titled “Discovery of New Therapeutics for Drug-Free Remission of HIV”, and a $50,000 grant from Epigenetx LLC for research titled “Characterization of Lysine Deacetylase Inhibitors (KDACIs).”
Marshall also was named a visiting professor at Sapienza Università di Roma in Italy for the spring semester. He had a similar appointment in fall 2011. While there, his collaborations with professors in the university’s School of Pharmacy led to NIH-supported research at Washington University.